Pfizer cuts 2022 earnings outlook despite strong first-quarter Covid vaccine and antiviral sales

Visits: 13

Pfizer said it sold $13.2 billion of its Covid vaccine and $1.5 billion of its antiviral treatment Paxlovid. Read More Go To Source